Anas Bahnassi
| Anas Bahnassi | |
|---|---|
 Anas Bahnassi in 2025.jpg Anas Bahnassi, 2024 | |
| Born | |
| 💼 Occupation | Pharmacist, educator, researcher |
| Known for | Studies on patient's safety, pharmacovigilance and pharmacy education in the Middle East and North America. |
| Anas Bahnassi | |
|---|---|
| Born | |
| 💼 Occupation | Pharmacy educator, researcher |
| Known for | research on pharmacy education, pharmacovigilance and patient's safety in the Middle East, the United States and Canada |
Anas Bahnassi is a pharmacy educator and researcher whose work focuses on pharmacy education and community pharmacy practice in the Middle East—particularly Syria, Lebanon, and Saudi Arabia—and in North America. His publications include qualitative and survey studies on non-prescription antibiotic sales, pharmacists’ pharmacovigilance knowledge and practice, and pharmacovigilance education in Lebanese pharmacy schools.[1][2][3][4]
Career
Early publications list affiliations with Taibah University (Saudi Arabia), examining pharmacists’ roles in safe access to prescription medicines and the non-prescription sale of antibiotics.[1][2] Later work lists Canadian affiliations with Rexall Pharmacy Group/McKesson Canada. A Canadian Pharmacists Journal feature during the COVID-19 pandemic included a statement credited to him in a frontline professional context, noting his Rexall role.[5] He also authored an overview of pharmacy education and practice in Syria.[6] In December 2021 he delivered an invited talk at Alfaisal University (Riyadh) on licensing and registration for foreign pharmacy graduates in Canada.[7]
Research
Bahnassi’s work spans pharmacy education and community pharmacy practice across Syria, Lebanon, Saudi Arabia, and Canada. In Syria, he reported on non-prescription sales of antibiotics and their implications for antimicrobial stewardship.[1] In Saudi Arabia, he explored pharmacists’ perspectives on dispensing antibiotics without prescriptions and suggested professional and regulatory approaches to improve counselling and access controls.[2] His survey of the Syrian pharmacovigilance system identified limited reporting experience among pharmacists and barriers such as uncertainty about report handling, unfamiliarity with forms, and modest publicity of the programme.[3] In Lebanon, he qualitatively assessed pharmacovigilance teaching in pharmacy schools and discussed integrating competencies into didactic and experiential components.[4]
Context: pharmacovigilance in Syria
An article in Uppsala Reports (Uppsala Monitoring Centre) noted that in October 2018 Syria’s pharmacovigilance unit became the 133rd member of the WHO Programme for International Drug Monitoring and described subsequent activities such as establishing hospital representatives, training, and receiving ADR reports from professionals and patients.[8]
Selected publications
- Bahnassi, Anas (June 2015). "A qualitative analysis of pharmacists' attitudes and practices regarding the sale of antibiotics without prescription in Syria" (PDF). Journal of Taibah University Medical Sciences. 10 (2): 227–233. doi:10.1016/j.jtumed.2014.09.001. Retrieved 28 August 2025.[1]
- Bahnassi, Anas (September 2016). "Pharmacists' views and practices in regard to sales of antibiotics without a prescription in Madinah, Saudi Arabia". Journal of Patient Safety. 12 (3): 159–164. doi:10.1097/PTS.0000000000000087. PMID 24647269.[2]
- Bahnassi, Anas; Al-Harbi, Fawaz (2018). "Syrian pharmacovigilance system: a survey of pharmacists' knowledge, attitudes and practices" (PDF). Eastern Mediterranean Health Journal. 24 (6): 569–578. doi:10.26719/2018.24.6.569. PMID 30079952. Retrieved 28 August 2025.[3]
- Bahnassi, Anas (22 April 2020). "A qualitative assessment of current pharmacovigilance education in Lebanese pharmacy schools". Medical Science Educator. 30 (2): 855–860. doi:10.1007/s40670-020-00963-8. PMC 8368960 Check
|pmc=value (help). PMID 34457742 Check|pmid=value (help).[4] - Bahnassi, Anas (April 2016). "Do no harm: the role of community pharmacists in regulating public access to prescription drugs in Saudi Arabia". International Journal of Pharmacy Practice. 24 (2): 142–145. doi:10.1111/ijpp.12224. PMID 26383607.
- Bahnassi, Anas (4 April 2020). "Pharmacy education and practice in Syria: past, present, and future". JACCP: Journal of the American College of Clinical Pharmacy. 3 (6): 1079–1084. doi:10.1002/jac5.1236. Retrieved 28 August 2025.[6]
- Abuirmeileh, Ayman; Bahnassi, Anas; Abuirmeileh, Amjad (April 2014). "Unexplained chronic leukopenia treated with oral iron supplements". International Journal of Clinical Pharmacy. 36 (2): 264–267. doi:10.1007/s11096-013-9897-2. PMC 7101904 Check
|pmc=value (help). PMID 24346817.
Influence
Bahnassi’s studies are cited in later work on antibiotic dispensing without prescription and pharmacy scholarship. Examples include a systematic review of non-prescription antibiotic dispensation[9] and an analysis of pharmacist-authored research trends.[10]
Talks
- "Pharmacist licensing and registration for foreign graduates in Canada". Alfaisal University College of Pharmacy News. 23 December 2021. Retrieved 28 August 2025.
External links
- Anas Bahnassi publications indexed by Google Scholar
References
- ↑ 1.0 1.1 1.2 1.3 Bahnassi, Anas (June 2015). "A qualitative analysis of pharmacists' attitudes and practices regarding the sale of antibiotics without prescription in Syria" (PDF). Journal of Taibah University Medical Sciences. 10 (2): 227–233. doi:10.1016/j.jtumed.2014.09.001. Retrieved 28 August 2025.
- ↑ 2.0 2.1 2.2 2.3 Bahnassi, Anas (September 2016). "Pharmacists' views and practices in regard to sales of antibiotics without a prescription in Madinah, Saudi Arabia". Journal of Patient Safety. 12 (3): 159–164. doi:10.1097/PTS.0000000000000087. PMID 24647269.
- ↑ 3.0 3.1 3.2 Bahnassi, Anas; Al-Harbi, Fawaz (2018). "Syrian pharmacovigilance system: a survey of pharmacists' knowledge, attitudes and practices". Eastern Mediterranean Health Journal. 24 (6): 569–578. doi:10.26719/2018.24.6.569. PMID 30079952. Retrieved 28 August 2025.
- ↑ 4.0 4.1 4.2 Bahnassi, Anas (22 April 2020). "A qualitative assessment of current pharmacovigilance education in Lebanese pharmacy schools". Medical Science Educator. 30 (2): 855–860. doi:10.1007/s40670-020-00963-8. PMC 8368960 Check
|pmc=value (help). PMID 34457742 Check|pmid=value (help). - ↑ "Pharmacists on the frontline". Canadian Pharmacists Journal. 153 (4): 186–190. 9 June 2020. doi:10.1177/1715163520930191. PMC 7605073 Check
|pmc=value (help). PMID 33193915 Check|pmid=value (help). - ↑ 6.0 6.1 Bahnassi, Anas (4 April 2020). "Pharmacy education and practice in Syria: past, present, and future". JACCP: Journal of the American College of Clinical Pharmacy. 3 (6): 1079–1084. doi:10.1002/jac5.1236. Retrieved 28 August 2025.
- ↑ "Pharmacist licensing and registration for foreign graduates in Canada". Alfaisal University College of Pharmacy News. 23 December 2021. Retrieved 28 August 2025.
- ↑ "Pharmacovigilance re-established in Syria". Uppsala Reports (Uppsala Monitoring Centre). 10 May 2019. Retrieved 28 August 2025.
- ↑ Batista, Ana D.; Rodrigues, Diego A.; Figueiras, Adolfo; Zapata-Cachafeiro, Maria; Pardo-Seco, Javier; Hernández, Jorge (7 November 2020). "Antibiotic dispensation without a prescription worldwide: a systematic review". Antibiotics. 9 (11): 786. doi:10.3390/antibiotics9110786. PMC 7690275 Check
|pmc=value (help). PMID 33171743 Check|pmid=value (help). - ↑ Strong, Delaney M.; Fuji, Kevin T. (1 February 2021). "A descriptive study examining trends in pharmacist-authored original research publications in the JAMA Network from 2000 to 2019". Pharmacy. 9 (1): 40. doi:10.3390/pharmacy9010040. PMC 7927262 Check
|pmc=value (help). PMID 33668619 Check|pmid=value (help).
This article "Anas Bahnassi" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Anas Bahnassi. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
